(R)-2-(methoxycarbonylamino)-2-phenylacetic acid - Names and Identifiers
(R)-2-(methoxycarbonylamino)-2-phenylacetic acid - Physico-chemical Properties
Molecular Formula | C10H11NO4
|
Molar Mass | 209.20 |
Density | 1.283±0.06 g/cm3(Predicted) |
Melting Point | 120 °C |
Boling Point | 391.3±35.0 °C(Predicted) |
pKa | 3.96±0.10(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
MDL | MFCD12796004 |
(R)-2-(methoxycarbonylamino)-2-phenylacetic acid - Introduction
(R)-2-(methoxycarbonylamino)-2-phenylacrylic acid is an organic compound with the chemical formula C11H13NO4. It is a white crystalline powder, soluble in some organic solvents such as ethanol and dimethylformamide.
(R)-2-(methoxycarbonylamino)-2-phenylacetic acid is usually used as a reagent in drug synthesis, mainly for the synthesis of biologically active peptide compounds. It can be used to synthesize peptide fragments with pharmaceutical activity, such as antibacterial peptides, anticancer peptides, etc. Its special structure makes it have important application value in the synthesis of complex peptide chains.
The preparation method of (R)-2-(methoxycarbonylamino)-2-phenylacetic acid is generally through the esterification reaction of phenylglycine and methyl formate to generate (R)-2-(methoxycarbonylamino)-2-phenylacetic acid methyl ester, which is then converted to (R)-2-(methoxycarbonylamino)-2-phenylacetic acid by a hydrolysis reaction.
Regarding safety information,(R)-2-(methoxycarbonylamino)-2-phenylacetic acid is relatively safe under correct use and storage conditions. However, it is an organic compound with certain potential dangers. During operation, care should be taken to avoid contact with skin and eyes and to avoid inhaling dust. Wear appropriate personal protective equipment such as gloves and goggles during use. At the same time, it should be operated under well-ventilated laboratory conditions to prevent the accumulation of harmful gases. In case of accidental contact or ingestion, seek medical help immediately.
Last Update:2024-04-09 21:11:58